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SMALL γ-RAY DOSES PREVENT RATHER THAN INCREASE LUNG TUMORS IN
MICE

B. R. Scott, V. R. Bruce, K. M. Gott, J. Wilder 䊐 Lovelace Respiratory Research
Institute, 2425 Ridgecrest Drive SE, Albuquerque, NM 87108
T. March
87104

䊐

Consultant Veterinary Pathologist, 3309 Beach Rd NW Albuquerque

We show evidence for low doses of γ rays preventing spontaneous hyperplastic foci and
adenomas in the lungs of mice, presumably via activating natural anticancer defenses. The
evidence partly relates to a new study we conducted whereby a small number of female A/J
mice received 6 biweekly dose fractions (100 mGy per fraction) of γ rays to the total body
which prevented the occurrence of spontaneous hyperplastic foci in the lung. We also analyzed data from a much earlier Oak Ridge National Laboratory study involving more than
10,000 female RFMf/Un mice whereby single γ-ray doses from 100 to 1,000 mGy prevented spontaneous lung adenomas. We point out the possibility that the decrease in lung cancer mortality observed in The National Lung Screening Trial Research Team study involving lung tumor screening using low-dose computed tomography (CT) may relate at least
in part to low-dose X-rays activating the body’s natural anticancer defenses (i.e., radiation
hormesis). This possibility was apparently not recognized by the indicated research team.

䊐
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INTRODUCTION

Humans worldwide have been and are currently exposed to low-level
ionizing radiation in excess of the natural background level, which varies
with geographical location. This includes radiation exposures during
radiological emergencies such as is ongoing in Japan related to the
Fukushima incident triggered by the March 2011 earthquake and tsunami. It also includes exposures related to applications of diagnostic medical devices (e.g., CT scans) and procedures (e.g., nuclear medicine)
(NCRP 2009). A key concern of many is the perceived low-level-radiation
exposure related elevated risk of cancer (McCollough et al. 2009). The
perceived risk is linked to the linear-no-threshold (LNT) hypothesis,
which implies that any amount of radiation, no matter how small, will
cause cancer in one or more members of a very large irradiated population (Muller 1954; Kathren 1996; Brenner and Hall 2007; Puskin 2009).
With the LNT-based, risk-assessment paradigm, each member of the irra-
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diated population (e.g., down-wind communities from the Fukushima
nuclear power facility) is led by experts to believe that they could with low
probability be a victim who develops cancer as a result of their exposure
to low-level radiation (Ten Hoeve and Jacobson 2012).
In the recent article by Ten Hoeve and Jacobson (2012) they attempted to quantify worldwide health effects (hypothetical cancers) of the
Fukushima Daiichi nuclear accident. The researchers used an atmospheric transport model to attempt to quantify the worldwide movement
of long-lived radionuclides (Cs-134, Cs-137, and I-131) released by the
Fukushima nuclear plant. The transport outside of Japan involved very
small amounts of added radiation. The researchers then incorporated the
calculated deposition of the transported radionuclides into a grid-model
of target populations and arrived at the collective dose (very small average individual dose multiplied times the very large population size).
Radiation health effects were supposedly accounted for using the LNT
model which can be implemented on the bases of the collective dose.
Using this approach, the authors calculated up to 1100 hypothetical cancer-related mortalities and up to 1800 hypothetical cancer-related morbidities worldwide. However, it is no longer acceptable to use collective
dose for the purpose of low-dose-radiation risk assessment for large populations (NCRP 1995). In addition, the LNT model is an invalidated
empirical model that unfortunately remains the basis for policy in radiation protection (Cohen 2008; Jaworowski 1999, 2008).
Historically, the LNT-based, risk-assessment paradigm has predominated, but now due in part to increasing evidence for beneficial effects
rather than harm from low-level radiation exposure, a radiation benefit
paradigm (Scott 2011) has emerged and is rapidly evolving. With the
novel radiation benefit paradigm, there is a hierarchy of presumably epigenetically-regulated, protective adaptive-response mechanisms that comprise a system of radiation activated nature protection (ANP).
Components of the ANP system include DNA damage repair, apoptosis of
damaged and aberrant cells (e.g., neoplastically transformed cells), anticancer immunity (including enhanced and more efficient tumor cell
killing), and suppression of cancer-promoting inflammation caused by
other agents (e.g., cigarette smoke carcinogens) (Kondo 1998; Trosko
1998; Wolff 1998; Rothkamm and Löbrich 2003; Sakai et al. 2003; Sakai
2006; Bauer 2007; Liu 2007; Cohen 2008; Jaworowski 2008; Scott 2008a,b;
Scott et al. 2008, 2009; Tubiana 2008; Averbeck 2009; Tubiana et al. 2009;
Nowosielska et al. 2012; Rödel et al. 2012; Sanders 2012).
Components of the radiation ANP system can be differentially activated by doses of radiation above the natural background level and the
activation is thought to involve epigenetic reprogramming (epireprogramming) of the genome (Scott et al. 2009). The epigenetic activation of protective adaptive-response genes has been called epiactivation (Scott et al.
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2009). Radiation doses much higher than encountered in nature promote epigenetically silencing (episilencing [Scott et al. 2009]) of adaptiveresponse genes and can significantly suppress the immune system (Liu
2007), facilitating development of cancer and other diseases. Low-doseradiation activation and high-dose-radiation suppression of protection
constitutes a hormetic response (i.e., radiation hormesis).
The indicated system of ANP appears to be more efficiently activated
by low linear-energy-transfer (LET) radiation than high-LET radiation
and this may relate to a link between the microscopic dose (e.g., to the
cell nucleus) distribution in space and in time and the intensity of the
protective intercellular signaling associated with ANP (Feinendegen et al.
2007a,b). It could also relate to life having originated in the oceans where
defense against low-LET radiation was likely needed early on rather than
defense against high-LET radiation because of the short range of a particles in water (Karam and Leslie 1999).
For combined exposure to low- and high-LET radiation as occurs for
radon in the environment and home and for mixed neutron and γ-ray
fields, harm from the high-LET component of the radiation dose appears
to be prevented by low-LET-radiation ANP (Rithidech and Scott 2008;
Sanders and Scott 2008; Scott et al. 2009; Sanders 2010). Further, low-LET
radiation ANP in animal models has delayed the occurrence of spontaneous cancer (Mitchel et al. 2003), prevented chemical-carcinogeninduced cancer (Sakai et al. 2003; Bruce et al. 2012), prevented cancer
metastasis (Hashimoto et al. 1999; Nowosielska et al. 2006), and extended
the lifespan of diseased animals (Sakai 2006; Lacoste-Collin et al. 2007).
Indeed, for low doses and dose rates of low-LET or low- plus high-LET
radiation (e.g., for residential radon), ANP rather than harm appears to
be more the rule than the exception (Sanders 2010; Scott 2011). The
benefit of radiation ANP for children is less clear (Scott et al. 2008)
although there is evidence for chronic low-rate exposure to γ rays being
protective (Chen et al. 2007) but not for computed-tomography-(CT)related X-rays (Pearce et al. 2012). However, there appears to be no unirradiated group in the CT study of Pearce et al. (2012), so that radiation
ANP for children cannot be ruled out.
Research results presented in this paper provide additional data supporting the low-dose-radiation benefit paradigm. We show data from a
study we conducted that demonstrates that repeated low doses of γ rays
(fractionated exposure) can prevent spontaneous hyperplastic foci in the
lung of mice. This is consistent with lung tumor data of other as is discussed in this paper.
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METHODS
Animals

Female, 10 week-old, A/J mice were purchased from Jackson
Laboratories (Bar Harbor, ME). At 42 weeks after the start of fractionated radiation exposure of 18 mice with 8 control unexposed mice, the
mice were humanely euthanized by i.p. injection of a lethal dose of
Euthasol.
Irradiation

The eighteen γ-ray exposure group mice received 6 biweekly fractions
of whole-body irradiation (WBI) (dose fraction size 100 mGy) using a
Gammacell 1000 irradiator (137Cs source) (Best Theratronics, Ontario,
CA). The 100 mGy dose fractions were delivered at 1.78 mGy sec-1. Mice
were exposed individually in polypropylene tubes set inside a stainless
steel sample canister. The dose received was evaluated based on nanoDot
dosimeters (Optically Stimulated Luminescence Technology, 1 cm2,
Landauer, Inc., Glenwood, IL) attached to the outside of the tubes containing the mice. Dose measurements obtained outside the exposure
tube were essentially the same as were obtained when nanoDots were
inserted into the chests of mouse carcasses, thus we relied on measurements obtained outside the exposure tubes. Control mice were not sham
exposed or placed in tubes. Sham exposure (no radiation) was not possible inside our Gammacell 1000 unit (Cs-137 source) because of ever-present leakage radiation.
Histology

Hyperplastic foci cases were used as a measure of increased lung cancer risk since the foci can progress to adenoma and then to carcinoma
(Bruce et al. 2012). To facilitate detecting the foci, lungs were inflated
with neutral buffered formalin at a constant hydrostatic pressure of 25 cm
for 6 hours and fixed further by immersion in formalin for > 48 hours.
Left lung lobes were systematically trimmed in a dorsoventral-transverse
direction at 3-4 mm intervals with the first slice randomly positioned within the cranial 4 mm of tissue to yield 3-5 slices per lobe. A single slice
along the axial airway of each of the right lung lobes was also made.
Trimmed tissue was histoprocessed routinely, and 5 μm-thick paraffin sections were mounted and stained with hematoxylin and eosin for lightmicroscopic identification and enumeration of hyperplastic foci and
other lesions. The distribution of hyperplastic foci cases among the 26
mice used in this study is presented in Table 1.
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TABLE 1. Hyperplastic foci among control and irradiated female A/J mice
Group

Hyperplastic foci per animal

Group

Hyperplastic foci per animal

1
1
1
0
0
1
0
1
1
0
0
1
1

Irradiated
Irradiated
Irradiated
Irradiated
Irradiated
Irradiated
Irradiated
Irradiated
Irradiated
Irradiated
Irradiated
Irradiated
Irradiated

0
1
0
0
0
0
1
0
0
0
0
0
1

Control
Control
Control
Control
Control
Control
Control
Control
Irradiated
Irradiated
Irradiated
Irradiated
Irradiated

Data Analysis and Modeling

The hyperplastic foci data in Table 1 were evaluated in the context of
a modified version of our hormetic relative risk (HRR) model (Scott
2011). Because animals had at most a single hyperplastic foci in the lung,
the foci case data were modeled as a Bernoulli random variable (foci present, response = 1; foci absent, response = 0) with different case probabilities for the controls and irradiated groups. For controls, the individualspecific probability (prob) of being a foci case is given by P. Had the animals received a single radiation dose, the individual-specific probability of
being a foci case would be given by the following equation:
prob = (1-profac•B(x))•P,

(1)

where profac is the individual-specific probability of the foci being prevented by γ-ray ANP (all protective mechanisms assumed activated). The
benefit function B(x) for radiation dose x is the probability of ANP. For
the 6 fractions radiation exposure scenario used, B(x) is assumed to be 1
(ANP for each individual).
To accommodate the 6-fraction exposure scheme, profac is replaced
by profacn, with n indicating the number of dose fractions used. Thus, for
the irradiated group, the probability of being a foci case is given by the
following equation:
prob = (1–profacn)•P,

(2)

with n taking on the value of 6 for six dose factions. In the analysis of the
data generated with the fractionated exposure, we have assumed each
dose fraction to be independent. This allows for evaluating profacn for n
531
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taking on other values, e.g., n = 1, 2, 3, …. The related mathematical relationships are provided in the Appendix.
Bayesian inference implemented via Markov chain Monte Carlo
(MCMC) (Lunn et al. 2000) was used to obtain posterior distributions for
P, profac6, and the product (1 – profac6)•P. With the HRR model the population average for profacn is PROFACn (the on-average proportion of the
population that do not develop the outcome of interest when ANP occurs
with probability 1). Thus, the population average, PROFAC6 for 6 fractions, was evaluated (estimated) as the posterior distribution mean for
profac6. During the generation of the posterior distribution for profac6,
posterior distributions were also generated for profac1, profac2, profac4, profac8, and profac16, assuming independent actions of the different fractions
(see the Appendix for more details). This allowed for estimating population averages PROFAC1, PROFAC2, PROFAC4, PROFAC8, and PROFAC16 in
addition to PROFAC6.
The prior distribution used for P was uniform from 0 to 1. The prior
distribution used for profac6 was uniform from 0 to 1. A single MCMC
chain was used. Convergence was assumed when ratio MCMC error/posterior distribution standard deviation < 0.05 for a given random variable
(Spiegelhalter et al. 2003). 25,000 iterations were used with 5,000 burn-in
(data points discarded). The choices of the total iterations and burn-in
were based on autocorrelation results obtained after the fist 5,000 iterations. The autocorrelation results indicated that convergence of the
chain could be assumed after the first 5,000 iterations (a conservative
choice). This was confirmed by checking to ensure that the ratio MCMC
error/posterior distribution standard deviation < 0.05 for each random
variable considered. A total of 20,000 data points per stochastic node
(i.e., stochastic parameter or function) of interest were retained for the
analysis carried out.
RESULTS

No spontaneous adenomas or carcinomas were found in controls and
none were found in irradiated mice. Regarding the data in Table 1, five
out of 8 control mice each had a single hyperplastic focus (incidence =
0.63 ± 0.17). Six out of the 18 irradiated mice each had a single hyperplastic focus (incidence = 0.33 ± 0.11). The standard errors reported are
based on assuming the number of foci cases per exposure group to have a
binomial distribution. Based on the central limit theorem, the average
incidence of foci cases after repeated γ-ray exposure would be expected to
have an approximate normal distribution. Figure 1 shows a normal distribution with mean of 0.33 (observed incidence for irradiated group) and
standard error of 0.11, with a point on the horizontal axis at the value of
0.63 (control incidence). The indicated results points to a significant protective effect of the fractionated γ-ray exposure (p < 0.005 implicated).
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FIGURE 1. Normal distribution with mean 0.33 and standard error 0.11. Single data point along the
horizontal axis at 0.63 represents the control incidence of hyperplastic foci.

TABLE 2. MCMC results for stochastic nodesa
Stochastic
node

Mean

St. dev.

MCMC error

5%

10%

50%

90%

95%

P
profac1
profac2
profac4
profac6
profac8
profac16
(1-profac6)•P

0.588
0.09
0.17
0.302
0.406
0.489
0.693
0.335

0.137
0.052
0.094
0.153
0.19
0.213
0.238
0.097

1.32E-03
5.08E-04
9.18E-04
1.52 E-03
1.91 E-03
2.16 E-03
2.46E-03
6.35 E-04

0.365
0.013
0.026
0.05
0.075
0.098
0.187
0.184

0.409
0.024
0.047
0.092
0.135
0.178
0.321
0.214

0.587
0.086
0.164
0.302
0.417
0.513
0.762
0.331

0.771
0.161
0.296
0.504
0.65
0.754
0.939
0.464

0.816
0.183
0.333
0.555
0.703
0.802
0.961
0.502

a

Stochastic parameter (e.g., profac6) or function [e.g., function = (1-profac6)•P].

The data in Table 1 have also been analyzed in the context of our
HRR model using the approach indicted in the Methods section and
Appendix of this paper. The posterior distribution means and percentiles
(5%, 10%, 50%, 90%, 95%) for stochastic nodes P, profac1, profac2, profac4,
profac6, profac8, profac16, and the product (1- profac6)*P are presented in
Table 2. The posterior distribution means for profacn are estimates of
PROFACn as already indicated. The posterior distributions were not
Gaussian. None of the posterior distributions had a mode located at zero
protection (2.5% percentile values were all > 0). A mode at zero protection would be expected in the absence of a γ-ray protective effect.
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DISCUSSION

Results in Table 2 are based on uniform prior distributions for P and
profac6. To assess the reliability of the results, evaluations were also carried
out using beta prior distributions for P and profac6 with the two parameters of the distribution set at 2 and 4. With this choice, the probability
density has the structure y(1-y)3, where y ( with 0 < y < 1) is replaced by P
or profac6 as appropriate. Posterior distribution means obtained with the
beta priors were systematically lower but differed by < 30 % from those
obtained with uniform priors indicating that the results presented in
Table 2 can be considered reasonably reliable.
Our finding of a protective effect of low-dose γ rays against spontaneous foci in the lung is consistent with data of Ullrich and Storer (1979)
showing the prevention of spontaneous lung adenomas in female
RFMf/Un mice by single doses of γ rays. A subset (lowest four dose groups
and controls) of the data of Ullrich and Storer (1979) for the age-adjusted lung adenoma incidence are presented in Table 3 and involved more
than 10,000 mice. The lung tumor relative risk was systematically reduced
by doses of 100, 250, 500, and 1000 mGy. We have calculated the corresponding values for PROFAC1, with all values being significantly > 0 (p <
0.05; based on PROFAC1 – 2 standard errors being > 0). This relates to the
central limit theorem indicating that average values tend to have an
approximate normal distribution. Even though the γ-ray doses ranged
from 100 to 1000 mGy, PROFAC1 was independent of the dose level (R2 =
0.00043; p > 0.5), indicating that all of the doses were in the central part
of the hormetic zone (Zone of Maximal Protection where ANP is expected for all animals so that B(x) = 1 [Scott 2011]).
The average and standard error for the measured 4 values of PROFAC1 are 0.27 ± 0.03, a significant protective effect (more than 1 out of
each 4 spontaneous adenomas cases prevented).

TABLE 3. Age-adjusted lung adenoma incidence data of Ullrich and Storer (1979) for female
RFMf/Un mice exposed to single γ-ray doses
Dose,
mGy

Number
of mice

Incidence

Incidence
standard error

PROFAC1

PROFAC1
standard errora

0
100
250
500
1000

4014
2827
965
1143
1100

0.302
0.239
0.202
0.22
0.225

0.015
0.017
0.027
0.025
0.027

0.209
0.331
0.272
0.255

0.069
0.095
0.09
0.097

a
Calculated via error propagation. Also equals the standard error for relative risk (RR) since for
data evaluated RR = 1 – PROFAC1 (a characteristic of the hormetic relative risk model for the Zone
of Maximal Protection [Scott et al. 2009; Scott 2011]).
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FIGURE 2. Benefit function B(x) estimate (upper curve) for low-dose-γ-ray stimulation of the body’s
natural defenses against spontaneous lung tumors (adenomas) in female RFMf/Un mice based on
data from Ullrich and Storer (1979) involving thousands of mice and the hormetic relative risk
model (Scott 2011). Also shown is the related prevention function (lower curve, B(x)•PROFAC1) for
lung cancer prevention. Points were simply joined by straight lines.

Figure 2 shows a plot of the values (estimates) of B(x) for lung tumor
prevention derived from the data of Ullrich and Storer (1979) with x representing the radiation dose in mGy. Also shown is a plot of the lung cancer prevention function (given by the product B(x)•PROFAC1). Data for the
1500 and 2000 mGy groups have been included. Full benefit (i.e., B(x) =
1) was assumed for doses of 100 to 1000 mGy, based on results of our correlation analysis already presented indicating that the dose range considered was likely within the Zone of Maximal Protection. The average of the
separate values of PROFAC1 presented Table 3 (i.e., 0.27) was used to calculate the other data points for B(x) at doses of 1500 and 2000 and also
the results for the prevention function. B(x) was evaluated based on the
following equation:
B(x) = (1 – RR(x))/average{PROFAC1}.

(3)

The notation average{} indicates that an average value for the enclosed
quantity is used. RR(x) is the lung tumor relative risk at dose x of radiation. The points in Figure 2 were simply joined by straight lines. The
results indicate that the threshold dose (value for which the prevention
function becomes zero) for causing excess (greater than spontaneous frequency) adenoma cases is around 2,000 mGy (2 Gy). Thus, the threshold
for lung adenoma induction by γ rays appears to be quite large for the
mouse strain studied.
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There are two possibilities related to the observed protective effects
of low-dose γ rays against spontaneous hyperplastic foci and adenomas in
the lung: (1) the lesion of interest (hyperplastic foci or lung adenoma)
was already present in the lung at the time the radiation exposure
occurred and was subsequently eliminated as a result of radiation ANP
(e.g., anticancer immunity); (2) the lesion of interest was not present at
the time of irradiation and the lesion was prevented from occurring at a
later time via radiation ANP.
Irrespective of the correct explanation for the radiation protective
effect, our findings have important implications related to the new guidelines that focus on only screening aged heavy smokers for lung cancer via
use of low-dose computed tomography (CT) rather than more widespread screening. New lung cancer screening guidelines from medical
groups recommend use of low-dose CT scans but only for persons 55 to
74 years of age and only for heavy smokers. The guides are based in part
on The National Lung Screening Trial Research Team (2011) publication that compared lung cancer mortality for persons screened with lowdose CT as compared to radiography (the latter which delivers a lower Xray dose than from CT but results in more difficulty in detecting tumors).
The study involved 53,454 persons at high risk of lung cancer and was carried out at 33 U.S. medical centers. The study demonstrated a significant
benefit of low-dose CT screening over screening with radiography so far
as reducing lung cancer mortality. The reduction was credited to more
reliable early diagnosis of lung tumors with low-dose CT because of better imaging. No consideration was given to the possibility that the higher
dose X-rays from CT scanning may have more efficiently stimulated the
body’s natural anticancer defenses (i.e., radiation hormesis) and this may
have helped to reduce lung cancer mortality.
There are now new data from our research group showing that
repeated low doses of γ rays can prevent cigarette-smoke-carcinogeninduced lung adenomas in mice. Bruce et al. (2012) show that 6 repeated
biweekly 100-mGy γ-ray doses prevent cigarette smoke carcinogen
benzo[a]pyrene (B[a]P) induced lung adenomas (but not carcinomas)
in female A/J mice followed for 46 weeks after B[a]P injection. The 6 γray dose fractions were given biweekly starting 1 month after B[a]P injection. Based on the indicated results, it is expected that repeated low doses
of X-rays would also prevent some cigarette-smoke-carcinogen-induced
adenomas in the lung. If so, then the rationale for limiting the lung cancer screening via low-dose CT to heavy smokers 55 to 74 years of age
needs to be reconsidered, especially for younger heavy smokers. The
scans could provide a previously unrecognized benefit, the reduction of
lung cancer incidence and mortality via radiation ANP.
The protective effects of low-dose γ rays we demonstrated are consistent with the observation that low-rate exposure to a small γ-ray dose can
536
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prevent lung tumor induction in rats by highly ionizing α particles (Scott
et al. 2008; Sanders 2010) and the observation that residential radon
(which involves both low-LET γ rays and high-LET a particles) appears to
prevent lung cancers caused by other agents (Thompson et al. 2008; Scott
2011). In addition, the benefit function, B(x), for lung cancer prevention
by residential radon (and progeny) exposure has a similar shape as in
Figure 2 when plotted against the average radon level in the home. The
radon benefit function B(x) and the related lung cancer prevention function (given by the product B(x)•PROFAC) based on the data of
Thompson et al. (2008) is presented in Figure 3. The central estimate of
the chronic exposure PROFAC of 0.52 (Scott 2011) was used in evaluating
the prevention function. Note that at and near the Environmental
Protection Agency’s action level of 4 pCi L-1 for residential radon, everyone appears to benefit from radon ANP (i.e., B(x) = 1 for Zone of
Maximal Protection). Equally important, for heavy smokers that would
normally develop lung cancer, 52% would be expected to have their cancers prevented as a result of their chronic residential radon exposure.
CONCLUSIONS

Low dose γ-rays prevent lung tumors in mice. The protection (an
adaptive response) is presumed to be due to radiation ANP which is
thought to be epigenetically regulated (Scott et al. 2009). Based on our
research findings, the recently-introduced, new guidelines for screening

FIGURE 3. Radon (residential) benefit function B(x) estimate (upper curve) for radon ANP against
lung cancer caused by smoking and by other agents based on data of Thompson et al. (2008) as analyzed by Scott (2011) in the context of the hormetic relative risk model. The benefit is presumed to
relate to the low-LET radiation component of the radiation dose. Also shown is the related prevention function (lower curve, B(x)•PROFAC) for lung cancer prevention. Points were simply joined by
straight lines.

537

Published by ScholarWorks@UMass Amherst, 2014

11

Dose-Response: An International Journal, Vol. 10 [2014], Iss. 4, Art. 10

B. R. Scott and others

heavy smokers for lung tumors using low-dose CT that is restricted to persons 55–74 years of age should be re-evaluated, especially for younger,
long-term, heavy smokers. The younger heavy smoker could benefit from
CT ANP against lung tumors which may also be the case for persons
55–74 years of age. In addition, further protection from smoking-related
lung cancer would be expected by residing long-term in homes with average radon concentrations at or near (below or above) the EPA’s action
level of 4 pCi L-1 of air.
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APPENDIX
Analytical Solution for profacn

An analytical solution was developed for profacn assuming that each
dose fraction acts independently. Thus, profac1 can be evaluated as a function of a known value for profac6 as follows:
1 – profac6 = (1 – profac1)6.

(A1)

profac1 = 1 – (1 – profac6)1/6.

(A2)

Thus,

Since Equation A1 also would apply when 6 is replaced by n for any
number of independent fractions, it follows that profacn for n = 2, 3, …,
can be evaluated as a function of profac1 using the following equation:
profacn = 1 – (1 – profac1)n.

(A3)

Equations A2 and A3 were used in our Bayesian analysis via Markov
chain Monte Carlo of the hyperplastic foci data presented in Table 1. As
the Bayesian analysis posterior distribution was generated for profac6
based on the data in hand, posterior distributions (projected distributions) were also obtained for profac1, profac2, profac4, profac8, and profac16.
For each value of profac6 comprising the posterior distribution, corresponding values for profac1 (Equation A2) and profacn (Equation A3, for n
= 2, 4, 8, and 16) were generated.
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